Evidence map›Paper›PMID 31553806›Full record

ArticleHepatology (Baltimore, Md.)2020

Hyperpolarized Metabolic Imaging Detects Latent Hepatocellular Carcinoma Domains Surviving Locoregional Therapy.

Nicholas R Perkons, Ryan M Kiefer, Michael C Noji, Mehrdad Pourfathi, Daniel Ackerman, Sarmad Siddiqui, David Tischfield, Enri Profka, Omar Johnson, Stephen Pickup and 8 more

Abstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Proof-of-Concept Study of Hyperpolarized [1-Radiology. Imaging cancer · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Scalable Hyperpolarized MRI Enabled by Ace-SABRE of [1-Angewandte Chemie (International ed. in English) · 2025
    Article
  7. HyperpolarizedMagnetic resonance in medicine · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Hyperpolarized carbon 13 MRI in liver diseases: Recent advances and future opportunities.Liver international : official journal of the International Association for the Study of the Liver · 2022
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Functional Genetic Screening Enables Theranostic Molecular Imaging in Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Nicholas R PerkonsPenn Image-Guided Interventions Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA.ORCID 0000-0003-4857-5375
Ryan M KieferPenn Image-Guided Interventions Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA.
Michael C NojiPenn Image-Guided Interventions Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-6996-5367
Mehrdad PourfathiDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Daniel AckermanPenn Image-Guided Interventions Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA.
Sarmad SiddiquiDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA.
David TischfieldPenn Image-Guided Interventions Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA.
Enri ProfkaPenn Image-Guided Interventions Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA.
Omar JohnsonPenn Image-Guided Interventions Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA.
Stephen PickupDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Anthony MancusoDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Austin PantelDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Michelle R DenburgDepartment of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA.
Gregory J NadolskiPenn Image-Guided Interventions Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA.
Stephen J HuntPenn Image-Guided Interventions Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA.
Emma E FurthDepartment of Pathology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Stephen KadlecekDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Terence P F GadePenn Image-Guided Interventions Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA.ORCID 0000-0001-8783-0661

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Image-Based Phenotyping of Hepatocellular Carcinoma Cell Survival Under Ischemic Stress: Toward Metabolic Imaging of Cancer Dormancy Using Hyperpolarized Carbon-13 TechnologyDP5OD021391 · OD · UNIVERSITY OF PENNSYLVANIA · PI GADE, TERENCE P · 2015 to 2019
$2.0M
Molecular imaging meets big data: a systems-level approach for application-driven, unbiased selection of metabolic imaging substrates for visualization of cancer dormancyF30CA232388 · NCI · UNIVERSITY OF PENNSYLVANIA · PI PERKONS, NICHOLAS RAINER · 2018 to 2020
$114k
NCATS NIH HHS UL1 TR000003NCI NIH HHS F30 CA232388NCRR NIH HHS UL1 RR024134NIH HHS DP5 OD021391NIH HHS DP5OD021391
6 · The paper itself

Abstract

BACKGROUND AND

aimsAdvances in cancer treatment have improved survival; however, local recurrence and metastatic disease-the principal causes of cancer mortality-have limited the ability to achieve durable remissions. Local recurrences arise from latent tumor cells that survive therapy and are often not detectable by conventional clinical imaging techniques. Local recurrence after transarterial embolization (TAE) of hepatocellular carcinoma (HCC) provides a compelling clinical correlate of this phenomenon. In response to TAE-induced ischemia, HCC cells adapt their growth program to effect a latent phenotype that precedes local recurrence. APPROACH AND

resultsIn this study, we characterized and leveraged the metabolic reprogramming demonstrated by latent HCC cells in response to TAE-induced ischemia to enable their detection in vivo using dynamic nuclear polarization (DNP) magnetic resonance spectroscopic imaging (MRSI) of

conclusionsThese studies provide a paradigm for imaging latent, treatment-refractory cancer cells, suggesting that DNP-MRSI provides a technology for this application.

Indexed as

Embolization, TherapeuticMagnetic Resonance SpectroscopyAnimalsCarcinoma, HepatocellularDisease Models, AnimalHumansLiver NeoplasmsMagnetic Resonance ImagingMaleRatsRats, Wistar

Identifiers

PMID31553806
PMCPMC7307779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.